JON STUDINGER: Open Payments
NPI 1912672544 · HOLLAND, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,510 in 118 payments from 24 companies in 2025. Trend: 2023 $1,573 · 2024 $2,179 · 2025 $2,510
Food & beverage: $2,317Education: $193
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $407 |
| GlaxoSmithKline, LLC. | 15 | $317 |
| Regeneron Healthcare Solutions, Inc. | 19 | $268 |
| GENZYME CORPORATION | 12 | $195 |
| Viatris Specialty LLC | 9 | $164 |
| JAZZ PHARMACEUTICALS INC. | 6 | $151 |
| Grifols USA, LLC | 4 | $111 |
| Avadel CNS Pharmaceuticals, LLC | 4 | $95 |
| Actelion Pharmaceuticals US, Inc. | 4 | $95 |
| SANOFI-AVENTIS U.S. LLC | 1 | $93 |
Products named: DUPIXENT, TEZSPIRE, NUCALA, YUPELRI, XYWAV, Prolastin-C Liquid, FASENRA, LUMRYZ.
Industry payments across MI — which companies pay providers there.
